Trial
NCT01816789
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Andros Day Surgery Clinic
Collaborators
—
Condition
In Vitro Fertilization
Intervention
rFSH
Why stopped
Optimal response: 63% nomogram, 42% controls, overcoming the stopping rule for interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-23